 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, July 6, 2005, 25(27):6467-6477; doi:10.1523/JNEUROSCI.1676-05.2005
Development/Plasticity/Repair
Identification of Dopaminergic Neurons of Nigral and Ventral Tegmental Area Subtypes in Grafts of Fetal Ventral Mesencephalon Based on Cell Morphology, Protein Expression, and Efferent Projections
Lachlan Thompson, Perrine Barraud, Elin Andersson, Deniz Kirik, andAnders Björklund Wallenberg Neuroscience Center, Department of Experimental Medical Research, and Lund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, SE-221 84 Lund, Sweden
Transplants of fetal ventral mesencephalic tissue are known to contain a mixture of two major dopamine (DA) neuron types: the A9 neurons of the substantia nigra pars compacta (SNpc) and the A10 neurons of the ventral tegmental area (VTA). Previous studies have suggested that these two DA neuron types may differ in their growth characteristics, but, because of technical limitations, it has so far been difficult to identify the two subtypes in fetal ventral mesencephalon (VM) grafts and trace their axonal projections. Here, we have made use of a transgenic mouse expressing green fluorescent protein (GFP) under the tyrosine hydroxylase promoter. The expression of the GFP reporter allowed for visualization of the grafted DA neurons and their axonal projections within the host brain. We show that the SNpc and VTA neuron subtypes in VM grafts can be identified on the basis of their morphology and location within the graft, and their expression of a G-protein-gated inwardly rectifying K+ channel subunit (Girk2) and calbindin, respectively, and also that the axonal projections of the two DA neuron types are markedly different. By retrograde axonal tracing, we show that dopaminergic innervation of the striatum is derived almost exclusively from the Girk2-positive SNpc cells, whereas the calbindin-positive VTA neurons project to the frontal cortex and probably also other forebrain areas. The results suggest the presence of axon guidance and target recognition mechanisms in the DA-denervated forebrain that can guide the growing axons to their appropriate targets and indicate that cell preparations used for cell replacement in Parkinson's disease will be therapeutically useful only if they contain cells capable of generating the correct nigral DA neuron phenotype.
Key words: tyrosine hydroxylase; green fluorescent protein; GFP; calbindin; Girk2; Parkinson's disease; transplantation
Received April 27, 2005; revised May 30, 2005; accepted June 2, 2005.
This article has been cited by other articles:
F. E. O'Keeffe, S. A. Scott, P. Tyers, G. W. O'Keeffe, J. W. Dalley, R. Zufferey, and M. A. Caldwell
Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease
Brain, March 1, 2008; 131(3): 630 - 641.
[Abstract] [Full Text] [PDF]
D. Yang, Z.-J. Zhang, M. Oldenburg, M. Ayala, and S.-C. Zhang
Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
Stem Cells, January 1, 2008; 26(1): 55 - 63.
[Abstract] [Full Text] [PDF]
L. Lin and O. Isacson
Axonal Growth Regulation of Fetal and Embryonic Stem Cell-Derived Dopaminergic Neurons by Netrin-1 and Slits
Stem Cells, November 1, 2006; 24(11): 2504 - 2513.
[Abstract] [Full Text] [PDF]
S.-L. Ang
Transcriptional control of midbrain dopaminergic neuron development
Development, September 15, 2006; 133(18): 3499 - 3506.
[Abstract] [Full Text] [PDF]
P. Soundararajan, G. B. Miles, L. L. Rubin, R. M. Brownstone, and V. F. Rafuse
Motoneurons derived from embryonic stem cells express transcription factors and develop phenotypes characteristic of medial motor column neurons.
J. Neurosci., March 22, 2006; 26(12): 3256 - 3268.
[Abstract] [Full Text] [PDF]
S. Johansson, I-H. Lee, L. Olson, and C. Spenger
Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions
Brain, December 1, 2005; 128(12): 2961 - 2976.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|